Unit of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
Clin Infect Dis. 2018 Jan 18;66(3):321-328. doi: 10.1093/cid/cix806.
Early treatment is pivotal for favorable outcome in acute bacterial meningitis (ABM). Lumbar puncture (LP) is the diagnostic key. The aim was to evaluate the effect on outcome of adherence to European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), and Swedish guidelines regarding neuroimaging before LP.
The cohort comprised 815 adult ABM patients in Sweden registered prospectively between 2008 and 2015. Primary endpoint was in-hospital mortality and secondary endpoint was favorable outcome at 2-6 months of follow-up.
Indications for neuroimaging before LP existed in 7%, 32%, and 65% according to Swedish, ESCMID, and IDSA guidelines, respectively. The adjusted odds ratio (aOR) was 0.48 (95% confidence interval [CI], .26-.89) for mortality and 1.52 (95% CI, 1.08-2.12) for favorable outcome if Swedish guidelines were followed. ESCMID guideline adherence resulted in aOR of 0.68 (95% CI, .38-1.23) for mortality and 1.05 (95% CI, .75-1.47) for favorable outcome. Following IDSA recommendations resulted in aOR of 1.09 (95% CI, .61-1.95) for mortality and 0.59 (95% CI, .42-.82) for favorable outcome. Performing prompt vs neuroimaging-preceded LP was associated with aOR of 0.38 (95% CI, .18-.77) for mortality and 2.11 (95% CI, 1.47-3.00) for favorable outcome. The beneficial effect of prompt LP was observed regardless of mental status and immunosuppression.
Adherence to Swedish guidelines in ABM is associated with decreased mortality and increased favorable outcome in contrast to adherence to ESCMID or IDSA recommendations. Our findings support that impaired mental status and immunocompromised state should not be considered indications for neuroimaging before LP in patients with suspected ABM.
急性细菌性脑膜炎(ABM)的良好预后关键在于早期治疗。腰椎穿刺(LP)是诊断的关键。本研究旨在评估欧洲临床微生物学和传染病学会(ESCMID)、美国传染病学会(IDSA)和瑞典指南关于 LP 前神经影像学检查的建议的遵循情况对结局的影响。
该队列纳入了 2008 年至 2015 年期间在瑞典前瞻性登记的 815 例成人 ABM 患者。主要终点是住院死亡率,次要终点是 2-6 个月随访时的良好结局。
根据瑞典、ESCMID 和 IDSA 指南,LP 前神经影像学检查的适应证分别为 7%、32%和 65%。如果遵循瑞典指南,死亡的调整优势比(aOR)为 0.48(95%置信区间[CI],0.26-0.89),良好结局的 aOR 为 1.52(95%CI,1.08-2.12)。遵循 ESCMID 指南的 aOR 为死亡率 0.68(95%CI,0.38-1.23),良好结局为 1.05(95%CI,0.75-1.47)。遵循 IDSA 建议的 aOR 为死亡率 1.09(95%CI,0.61-1.95),良好结局为 0.59(95%CI,0.42-0.82)。与 LP 前神经影像学检查相比,快速进行 LP 与死亡率的 aOR 为 0.38(95%CI,0.18-0.77)和良好结局的 aOR 为 2.11(95%CI,1.47-3.00)相关。无论意识状态和免疫抑制情况如何,快速 LP 的有益效果都观察到了。
与遵循 ESCMID 或 IDSA 建议相比,ABM 中遵循瑞典指南与死亡率降低和良好结局增加相关。我们的研究结果支持在疑似 ABM 患者中,不应将意识状态受损和免疫抑制状态视为 LP 前神经影像学检查的适应证。